For the next-generation growth technology, Daewoong focuses R&D power on biologics research, and one of the main goals is to develop therapeutic agents using stem cells. Daewoong develops therapeutic drugs using ES-derived Mesenchymal Stem Cells. Ko-eun will introduce the technology that Daewoong has achieved so far.
Ko-eun is in charge of cellular therapeutics business development and strategic planning at Daewoong Pharmaceutical. Ko-eun has worked on a collaborative project with researchers to develop therapeutics in human and canine, and a proven expertise in Open Collaboration, a special program of Daewoong. Currently Daewoong seeks university researchers, suppliers, and prominent biotechnology companies throughout the world to successfully commercialize our promising products.
She has a bachelor's degree from Sookmyung Women's University in business management.